Leef Brands (LEEEF) Raw Materials (2024 - 2026)
Leef Brands (LEEEF) posted Raw Materials of $1.2 million for Q1 2026, up 34.35% sequentially from $889784.0 in Q4 2025.
Leef Brands (LEEEF) Raw Materials (2024 - 2026) Analysis & Trends
Leef Brands has reported Raw Materials for 3 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Raw Materials changed N/A year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $889784.0, down 34.09% from the prior year.
- Raw Materials advanced to $1.2 million in Q1 2026 per LEEEF's latest filing, from $889784.0 in the prior quarter.
- Over five years, Raw Materials peaked at $1.3 million in Q4 2024 and troughed at $889784.0 in Q4 2025.
- A 3-year average of $1.1 million and a median of $1.2 million in 2026 frame the typical range for Raw Materials.
- The widest YoY moves for Raw Materials: up 34.09% in 2025, down 34.09% in 2025.
- Over 3 years, Raw Materials stood at $1.3 million in 2024, then tumbled by 34.09% to $889784.0 in 2025, then jumped by 34.35% to $1.2 million in 2026.
- According to Business Quant data, Raw Materials over the past three periods registered $1.2 million, $889784.0, and $1.3 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 889,784.00 |
| Dec 31, 2024 | 1.35 Mn |